EMBL Agri-Tech Partnership to deliver safe food and environmental health
The partnership will address global food security challenges through optimised agricultural research and data-driven innovation.
CONNECTIONS2024
connections
EMBL Science Day with Evonik: fostering collaborative innovations
EMBL hosted a Science Day with Evonik, bringing together 16 industry experts and EMBL scientists to explore collaborative research opportunities.
CONNECTIONS2024
connections
IIT-EMBL: New molecules to modulate gene expression
A new research paper published in Nature Communications lays the groundwork for the development of new drugs specific to genetic mutations or alterations responsible for the onset of tumours or genetic diseases.
SCIENCE & TECHNOLOGY2024
science-technology
Inaugural ‘From Lab to Launch’ event ignites entrepreneurial spirit among scientists
This event bridged research and entrepreneurship, fuelling innovation and discovery. Attendees immersed themselves in insightful discussions and invaluable networking opportunities, inspired to journey from lab research to entrepreneurial success.
CONNECTIONS2024
connections
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of an epigenetic editing system that allows to precisely program chromatin modifications at any specific position in the genome, to understand their causal role in transcription regulation.
SCIENCE & TECHNOLOGY2024
science-technology
Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
EMBL and ZEISS enter long-term strategic partnership
Through the collaborative framework agreement, EMBL and ZEISS aim to accelerate the development of imaging technology to advance life science research.
CONNECTIONSLAB MATTERS2023
connectionslab-matters
We are EMBL: Jürgen Bauer on translating ideas into applications
Jürgen Bauer talks about translating science into applications with societal benefit, his journey from the lab bench to business development, and technology transfer at EMBL.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
Promoting European innovation in the life sciences
One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…
CONNECTIONSLAB MATTERS2023
connectionslab-matters
Teamed up to innovate
A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
CONNECTIONSLAB MATTERS2022
connectionslab-matters
Investing in Italy by translating EMBL expertise to the market
Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
LAB MATTERSSCIENCE & TECHNOLOGY2022
alumnilab-mattersscience-technologytechnology-and-innovation
Structural biology at EMBL: driving technology development
Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
ALPX – smart crystallography
The CrystalDirect® technology, combined with the web-based CRIMS software enable a fully automated, remote-controlled protein-to-structure pipeline.
LAB MATTERS2020
lab-matters
Twenty years of EMBLEM
Reflecting on 20 years of EMBLEM
LAB MATTERS2019
lab-matters
EMBL spinoff to help antibody discovery
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
LAB MATTERSSCIENCE & TECHNOLOGY2018
lab-mattersscience-technology
EMBL spin-off Luxendo acquired by Bruker
Accelerating researchers’ access to next-generation light-sheet microscopy
CONNECTIONSLAB MATTERS2017
connectionslab-matters
New EMBL and GSK collaboration
GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
CONNECTIONSLAB MATTERS2017
connectionslab-matters
SPIM doctors
From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
Lighting the way
A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
LAB MATTERSSCIENCE & TECHNOLOGY2015
lab-mattersscience-technology
The transparent organism
A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…
CONNECTIONS2005
connections
No results found